BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14501787)

  • 1. Emergence of protease inhibitor resistance-associated mutations in plasma HIV-1 precedes that in proviruses of peripheral blood mononuclear cells by more than a year.
    Bi X; Gatanaga H; Ida S; Tsuchiya K; Matsuoka-Aizawa S; Kimura S; Oka S
    J Acquir Immune Defic Syndr; 2003 Sep; 34(1):1-6. PubMed ID: 14501787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART.
    Chew CB; Potter SJ; Wang B; Wang YM; Shaw CO; Dwyer DE; Saksena NK
    J Clin Virol; 2005 Jul; 33(3):206-16. PubMed ID: 15911442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Niubó J; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2012; 17(3):577-83. PubMed ID: 22301439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients.
    Paolucci S; Baldanti F; Campanini G; Zavattoni M; Cattaneo E; Dossena L; Gerna G
    J Med Virol; 2001 Oct; 65(2):207-17. PubMed ID: 11536225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of a long-term discrepancy in drug-targeted genes in plasma HIV-1 RNA and PBMC HIV-1 DNA in the same patient.
    Usuku S; Noguchi Y; Sakamoto M; Adachi T; Sagara H; Sudo K; Nishizawa M; Kondo M; Tochikubo O; Imai M
    Jpn J Infect Dis; 2006 Apr; 59(2):122-5. PubMed ID: 16632914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly diversified multiply drug-resistant HIV-1 quasispecies in PBMCs: a case report.
    Quan Y; Brenner BG; Dascal A; Wainberg MA
    Retrovirology; 2008 May; 5():43. PubMed ID: 18513421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling resistance-related mutations in the protease region of the pol gene: single genome sequencing of HIV in plasma and peripheral blood mononuclear cells.
    Guimarães AP; Sa-Filho DJ; Sucupira MC; Janini LM; Diaz RS
    AIDS Res Hum Retroviruses; 2008 Jul; 24(7):969-71. PubMed ID: 18593345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.
    Re MC; Vitone F; Biagetti C; Schiavone P; Alessandrini F; Bon I; de Crignis E; Gibellini D
    Clin Microbiol Infect; 2010 Jun; 16(6):640-6. PubMed ID: 19732081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-resistant variants that evolve during nonsuppressive therapy persist in HIV-1-infected peripheral blood mononuclear cells after long-term highly active antiretroviral therapy.
    Verhofstede C; Noë A; Demecheleer E; De Cabooter N; Van Wanzeele F; Van Der Gucht B; Vogelaers D; Plum J
    J Acquir Immune Defic Syndr; 2004 Apr; 35(5):473-83. PubMed ID: 15021312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.
    Ghosn J; Pellegrin I; Goujard C; Deveau C; Viard JP; Galimand J; Harzic M; Tamalet C; Meyer L; Rouzioux C; Chaix ML;
    AIDS; 2006 Jan; 20(2):159-70. PubMed ID: 16511408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing.
    Sarmati L; Nicastri E; Uccella I; D'Ettorre G; Parisi SG; Palmisano L; Galluzzo C; Concia E; Vullo V; Vella S; Andreoni M
    J Clin Microbiol; 2003 Apr; 41(4):1760-2. PubMed ID: 12682180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.
    Parisi SG; Boldrin C; Cruciani M; Nicolini G; Cerbaro I; Manfrin V; Dal Bello F; Franchin E; Franzetti M; Rossi MC; Cattelan AM; Romano L; Zazzi M; Andreoni M; Palù G
    J Clin Microbiol; 2007 Jun; 45(6):1783-8. PubMed ID: 17442799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART.
    Monno L; Punzi G; Scarabaggio T; Saracino A; Brindicci G; Fiore JR; Iambrenghi OC; Di Stefano M; Pastore G; Angarano G
    J Med Virol; 2003 May; 70(1):1-9. PubMed ID: 12629636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
    Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A
    J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential evolution of cell-associated virus in blood and genital tract of HIV-infected females undergoing HAART.
    Tirado G; Jove G; Reyes E; Sepulveda G; Yamamura Y; Singh DP; Kumar A
    Virology; 2005 Apr; 334(2):299-305. PubMed ID: 15780880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of HIV-1 drug-resistant variants in plasma and peripheral blood mononuclear cells from untreated individuals: implications for clinical management.
    Bon I; Alessandrini F; Borderi M; Gorini R; Re MC
    New Microbiol; 2007 Jul; 30(3):313-7. PubMed ID: 17802917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients.
    Devereux HL; Loveday C; Youle M; Sabin CA; Burke A; Johnson M
    AIDS Res Hum Retroviruses; 2000 Jul; 16(11):1025-30. PubMed ID: 10933616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men.
    Ghosn J; Viard JP; Katlama C; de Almeida M; Tubiana R; Letourneur F; Aaron L; Goujard C; Salmon D; Leruez-Ville M; Rouzioux C; Chaix ML
    AIDS; 2004 Feb; 18(3):447-57. PubMed ID: 15090797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to protease inhibitors.
    Kuritzkes DR
    J HIV Ther; 2002 Nov; 7(4):87-91. PubMed ID: 12733606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.